Inventor

CLAGETT-DAME MARGARET

US105 patents

⚠️ This page may combine multiple inventors who share the name “CLAGETT-DAME MARGARET”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CLAGETT-DAME MARGARET

WISCONSIN ALUMNI RES FOUND

(20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses

1α-hydroxy-2-methylene-19-nor-homopregnacalciferol and its uses

(20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses

2-methylene-1α,25-dihydroxy-19,21-dinorvitamin D3 analogs and uses thereof

Vitamin D analog—NEL, methods and uses thereof

2-methylene-19-nor-1alpha-hydroxy-17-ene-homopregnacalciferol and its uses

19,26,27-trinor-1α,25-dihydroxyvitamin D3 compounds

17,20(Z)-dehydro vitamin D analogs and their uses

2α-Methyl and 2β-methyl analogs of 19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and their uses

17,20(E)-dehydro vitamin D analogs and their uses

1α-hydroxy-2-methylene-19-nor-homopregnacalciferol and its uses

2-methylene-19-nor-20(S)-1α-hydroxy-bis-homo-pregnacalciferol in crystalline form

Preparations and use of an Ah receptor ligand, 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester

Use of aryl hydrocarbon receptor ligand as a therapeutic intervention in angiogenesis-implicated disorders

Modified retinoid compounds and their uses

Vitamin D analog—RAK, methods and uses thereof

(20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses

2-Methylene-(20R,25S)-19,27-Dinor-(22E)-Vitamin D Analogs

(20S)-23,23-difluoro-methylene-19-nor-bishomopregnacalciferol-vitamin D analogs

(20R)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin D analogs

2-methylene-19-nor-(20S-24S)-1α,25-dihydroxyvitamin-D2

2-methylene-19-nor-(20S)-1α-hydroxy-trishomopregnacalciferol

(20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses

2-methylene-19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and its uses

Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism

Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism

Vitamin D receptor antagonists and their use in treating asthma

Method of reducing toxicity of retinoids

(20S)-1α-Hydroxy-2-Methylene-19-Nor-Bishomopregnacalciferol and its uses

2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin D3 and uses thereof

2-methylene-1α-hydroxy-19,21-dinorvitamin D3 analogs and uses thereof

2-methylene-19-nor-(23S)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone

2-Methylene-18,19-dinor-1α-hydroxy-homopregnacalciferol and its uses

2-methylene-19-nor-(23S)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone

Use of 2-methylene-19-nor-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism in patients previously treated with calcimimetics

17,20(E)-dehydro vitamin D analogs and their uses

2-methylene-19-nor-1α-hydroxy-17-ene-homopregnacalciferol and its uses

Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to prevent secondary hyperparathyroidism or the symptoms thereof

(22E)-2-methylene-22-dehydro-1α,24,25-trihydroxy-19-nor-vitamin D3 analogs

2-methylene-(20S,25S)-19,26-dinor-vitamin D analogs

Modified retinoid compounds and their uses

DELUCA HECTOR F

Once-a-week administration of 25-hydroxy vitamin D3 to sustain elevated steady-state pharmacokinetic blood concentration

Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3

2-substituted-1α,25-dihydroxy-19,26,27-trinor vitamin D analogs and uses thereof

(20R)-2α-methyl-19,26,2-trinor-vitamin D analogs

2α-methyl-19-nor-(20S)-1α-hydroxy-bishomopregnacalciferol and its uses

WISCONSIN ALUMNI RES FOUDATION

1 α-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses

WISCONSIN ALUMI RES FOUNDATION

2α-methyl-19-nor-(20S)-1α-hydroxy-bishomopregnacalciferol and its uses

UNIV OHIO STATE RES FOUND

C-linked analogs of N-(4-hydroxyphenyl) retinamide

CLAGETT-DAME MARGARET

Vitamin D analogs for obesity prevention and treatment